Subsequently, inhibition of PPARγ abrogates the beneficial effects of sEH inhibition in various diseases [83,84,85], and inhibition of PPARα abrogated the protective effect of TPPU on steatosis in mice in the study by Yao et al. [45]. This evidence concerns the gene EPHX2 and steatosis.